THE RESTORATIVE EFFECTS OF PULSED INFRARED LIGHT THERAPY ON SIGNIFICANT LOSS OF PERIPHERAL PROTECTIVE SENSATION IN PATIENTS WITH LONG TERM TYPE 1 AND TYPE 2 DIABETES MELLITUS.

2005 ◽  
Vol 16 (4) ◽  
pp. 31
Author(s):  
David A. Arnall ◽  
Arnold G. Nelson ◽  
Laura Lopez ◽  
Nuria Sanz ◽  
Louise Iversen ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Light Therapy ◽  
Significant Loss ◽  
Infrared Light ◽  
Protective Sensation ◽  
Peripheral Protective Sensation ◽  
Term Type

Pulsed infrared light therapy does not increase nitric oxide concentration in the blood of patients with type 1 and type 2 diabetes mellitus

2008 ◽  
Vol 46 (3) ◽  
pp. 233-237 ◽  
Author(s):  
David Alan Arnall ◽  
Arnold G. Nelson ◽  
Laura Stambaugh ◽  
Núria Sanz Sevilla ◽  
M. Àngels Cebrià i Iranzo ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Light Therapy ◽  
Infrared Light ◽  
Oxide Concentration ◽  
Nitric Oxide Concentration

scholarly journals Imaginary Worlds: The Status of Simulation Modeling in Claims for Cost-Effectiveness In Diabetes Mellitus

2016 ◽  
Vol 7 (2) ◽  
Author(s):  
Paul C Langley ◽  
Taeho Greg Rhee
Keyword(s):  
Diabetes Mellitus ◽  
Cost Effectiveness ◽  
Simulation Modeling ◽  
Decision Makers ◽  
The Past ◽  
The Status ◽  
The Impact

Over the past 20 years a number of simulations or models have been developed as a basis for tracking and evaluating the impact of pharmacological and other interventions in type 1 and type 2 diabetes mellitus. These models have typically tracked the natural course of these diseases generating long-term composite claims for cost-effectiveness. These claims can extend over the lifetime of the modeled patient cohort. Set against the standards of normal science, however, these claims lack credibility. The claims presented are all too often either immune to failure or are presented in a form that is non-testable. As such they fail to meet the key experimental requirements of falsification and replication. Unfortunately, there is a continuing belief that long-term or lifetime models are essential to decision-making. This is misplaced. The purpose of this review is to argue that there is a pressing need to reconsider the needs of health system decision makers and focus on modeled or simulated claims that are meaningful, testable, reportable and replicable in evaluating interventions in diabetes mellitus.   Type: Commentary

Rapid gastric emptying of a liquid meal in long-term Type 2 diabetes mellitus

1998 ◽  
Vol 15 (12) ◽  
pp. 1022-1027 ◽  
Author(s):  
C. Weytjens ◽  
B. Keymeulen ◽  
C. Van Haleweyn ◽  
G. Somers ◽  
A. Bossuyt
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Gastric Emptying ◽  
Liquid Meal ◽  
Term Type

scholarly journals Neuropeptide Y autoantibodies in patients with long-term type 1 and type 2 diabetes and neuropathy

2013 ◽  
Vol 27 (6) ◽  
pp. 609-617 ◽  
Author(s):  
Hanna Skärstrand ◽  
L.B. Dahlin ◽  
Å. Lernmark ◽  
F. Vaziri-Sani
Keyword(s):  
Type 2 Diabetes ◽  
Neuropeptide Y ◽  
Term Type

Neurovisual abnormalities preceding the retinopathy in patients with long-term type 1 diabetes mellitus

2001 ◽  
Vol 239 (9) ◽  
pp. 643-648 ◽  
Author(s):  
Jacqueline Lopes de Faria ◽  
Osamu Katsumi ◽  
Enrico Cagliero ◽  
David Nathan ◽  
Tatsuo Hirose
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Term Type

Association between microfibrillar-associated protein 4 (MFAP4) and micro- and macrovascular complications in long-term type 1 diabetes mellitus

2016 ◽  
Vol 54 (4) ◽  
pp. 367-372 ◽  
Author(s):  
S.L. Blindbæk ◽  
A. Schlosser ◽  
A. Green ◽  
U. Holmskov ◽  
G.L. Sorensen ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Macrovascular Complications ◽  
Term Type
Sign in / Sign up

Export Citation Format

Share Document